| abstract |
The present invention relates to compounds of formula (I), pharmaceutically acceptable salts thereof or prodrugs thereof.n n n <Formula I>n n n n n n n n Wheren n n (1) Ring A is an unsubstituted or substituted unsaturated monocyclic heterocyclic ring, and Ring B is an unsubstituted or substituted unsaturated monocyclic heterocyclic ring, an unsubstituted or substituted unsaturated fused heterobicyclic ring Or an unsubstituted or substituted benzene ring,n n n (2) Ring A is an unsubstituted or substituted benzene ring, Ring B is an unsubstituted or substituted unsaturated monocyclic heterocyclic ring, or an unsubstituted or substituted unsaturated fused heterobicyclic ring, orn n n (3) Ring A is an unsubstituted or substituted unsaturated fused heterobicyclic ring, and Ring B is independently an unsubstituted or substituted unsaturated monocyclic heterocyclic ring, an unsubstituted or substituted unsaturated fused heterobicyclic ring Ring, or an unsubstituted or substituted benzene ring;n n n X is a carbon atom or a nitrogen atom;n n n Y is-(CH 2 ) n- ;n n n n is 1 or 2.n n n Sodium-dependent glucose transporter, diabetes, diabetic complications, obesity, hypertension, atherosclerosis, hyperglycemia, hyperlipidemia |